Partner Stan Fisher and associate Michael Liu will present the upcoming CLE Program “Navigating Venue and Multi-District Litigation in Hatch-Waxman Cases” on April 22nd at 1:00pm. The program will examine the Federal Circuit’s decision in Valeant Pharmaceuticals v. Mylan Pharmaceuticals, which clarified venue for Hatch-Waxman cases by holding that infringement occurs only where the ANDA filer took actions related to its ANDA submission, thereby resolving a split among district courts post-TC Heartland. It will address the impact of Valeant on Hatch-Waxman litigation, including how it affects where cases can be filed and litigated, including through use of the Multi-District Litigation process.
Click here to learn more about the program and register.